# Hims & Hers gains as FDA panel endorses peptide BPC-157 (HIMS) - Seeking Alpha

*Источник: Seeking Alpha*
*Дата: 2026-07-23*
*Язык: en*

**Кратко:** Shares of Hims & Hers Health (HIMS) rose more than 10% on Thursday after an FDA advisory panel âvoted to include a popular peptide known as âBPC-157 in a list of molecules that compounding pharmacies are permitted to use
Shares of Hims & Hers Health (HIMS) rose more than 10% on Thursday after an FDA advisory panel âvoted to include a popular peptide known as âBPC-157 in a list of molecules that compounding pharmacies are permitted to use

Shares of Hims & Hers Health (HIMS) rose more than 10% on Thursday after an FDA advisory panel âvoted to include a popular peptide known as âBPC-157 in a list of molecules that compounding pharmacies are permitted to use
Shares of Hims & Hers Health (HIMS) rose more than 10% on Thursday after an FDA advisory panel âvoted to include a popular peptide known as âBPC-157 in a list of molecules that compounding pharmacies are permitted to use

[Оригинал](https://seekingalpha.com/news/4617588-hims-hers-gains-fda-panel-endorses-peptide-bpc-157)